Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase the proportion of people on Medicare with chronic kidney disease who get recommended tests — CKD‑04

Status: Improving

  
Improving
Learn more about our data release schedule

Most Recent Data:
38.1 percent (2022)

Target:
48.3 percent 1

Desired Direction:
Increase desired

Baseline:
35.5 percent of Medicare beneficiaries aged 65 years and over with chronic kidney disease received medical evaluation with serum creatinine, lipids, and urine albumin tests in 2016 2

See detailed data for this objective

Increase the proportion of Medicare beneficiaries with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and urine albumin tests

Target-Setting Method
Projection

Data Source:  United States Renal Data System (USRDS), NIH/NIDDK

Learn more about data measurement for this objective

Summary

Testing for serum creatinine, lipids, and urine albumin is important in people with chronic kidney disease (CKD). Health care providers can use these tests to see how well kidneys are working, find out if CKD has gotten worse, and decide the best course of treatment. Research has shown that using these 3 tests can help prevent or delay end-stage kidney disease.

Topics:  Chronic Kidney Disease, Diabetes, Health Care

Workgroup: Chronic Kidney Disease Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives

1. Target has been revised. See Data Methodology and Measurement for more information.

2. Baseline has been revised. See Data Methodology and Measurement for more information.